Why now? Polls suggest that seventy four% of Americans are not able to afford their medications, and Trump faces force to lower inflation and health treatment costs. Congressional leaders are presently drafting legislation that may enable the federal governing administration to negotiate the price of superior-cost drugs and those freshly moving